Literature DB >> 28189654

Strategies to improve the affordability of insulin in the USA.

Jing Luo1, Aaron S Kesselheim2, Jeremy Greene3, Kasia J Lipska4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28189654     DOI： 10.1016/S2213-8587(17)30041-4

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN： 2213-8587            Impact factor:   32.069


× No keyword cloud information.
  6 in total

1.  Implementation of a Health Plan Program for Switching From Analogue to Human Insulin and Glycemic Control Among Medicare Beneficiaries With Type 2 Diabetes.

Authors:  Jing Luo; Nazleen F Khan; Thomas Manetti; Jim Rose; Ani Kaloghlian; Balu Gadhe; Sachin H Jain; Joshua J Gagne; Aaron S Kesselheim
Journal:  JAMA       Date:  2019-01-29       Impact factor: 56.272

Review 2.  One hundred years of insulin therapy.

Authors:  Chantal Mathieu; Pieter-Jan Martens; Roman Vangoitsenhoven
Journal:  Nat Rev Endocrinol       Date:  2021-08-17       Impact factor: 43.330

3.  Changing costs of type 1 diabetes care among US children and adolescents.

Authors:  Stephanie Crossen; Guibo Xing; Jeffrey S Hoch
Journal:  Pediatr Diabetes       Date:  2020-03-02       Impact factor: 4.866

Review 4.  Availability and Affordability of Essential Medicines: Implications for Global Diabetes Treatment.

Authors:  David Beran; Margaret Ewen; Kasia Lipska; Irl B Hirsch; John S Yudkin
Journal:  Curr Diab Rep       Date:  2018-06-16       Impact factor: 4.810

Review 5.  Origins of the Crisis in Insulin Affordability and Practical Advice for Clinicians on Using Human Insulin.

Authors:  Jing Luo; Walid F Gellad
Journal:  Curr Diab Rep       Date:  2020-01-29       Impact factor: 5.430

6.  Can we do for other essential medicines what we are doing for the COVID-19 vaccine?

Authors:  Adrianna Murphy; Lilian Mbau; Martin McKee; Kara Hanson; Els Torreele
Journal:  BMJ Glob Health       Date:  2021-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.